The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

被引：0
|
作者：
Clyde Thornsberry
P. Ogilvie
H. P. Holley
M. L. Hickey
M. E. Jones
I. A. Critchley
D. F. Sahm
机构：
[1] MRL Pharmaceutical Services,
[2] Home Healthcare Labs of America,undefined
[3] Glaxo Wellcome Inc.,undefined
[4] MRL Pharmaceutical Services,undefined
[5] MRL Pharmaceutical Services,undefined
来源：
Drugs | 1999年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：346 / 348
页数：2
相关论文
共 50 条
  • [21] COMPARATIVE ANTIBACTERIAL ACTIVITY OF CEFPODOXIME AGAINST HAEMOPHILUS-INFLUENZAE, STREPTOCOCCUS-PYOGENES, STREPTOCOCCUS-PNEUMONIAE, AND MORAXELLA-CATARRHALIS
    WALLRAUCHSCHWARZ, C
    MILATOVIC, D
    BRAVENY, I
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1994, 44-1 (05): : 668 - 670
  • [22] ANTIBACTERIAL ACTIVITY OF CEFIXIME AGAINST STREPTOCOCCUS-PNEUMONIAE, STREPTOCOCCUS-PYOGENES, AND HAEMOPHILUS-INFLUENZAE IN THE PRESENCE OF MORAXELLA (BRANHAMELLA) CATARRHALIS
    YAMADA, T
    YOKOTA, Y
    IKEDA, F
    MINE, Y
    KITADA, T
    [J]. CHEMOTHERAPY, 1992, 38 (01) : 28 - 35
  • [23] In vitro activity of Grepafloxacin against Haemophilus influenzae and Moraxella catarrhalis
    Maskell, JP
    Whiley, AC
    Sefton, AM
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (04) : 293 - 295
  • [24] Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US
    Karlowsky, JA
    Draghi, DC
    Thornsberry, C
    Jones, ME
    Critchley, IA
    Sahm, DF
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (02) : 76 - 85
  • [25] Comparative in vitro activity of cefprozil against respiratory isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis:: results of a multicenter study
    Hasdemir, U
    Gur, D
    Akgun, H
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S139 - S139
  • [26] Antimicrobial resistance of Streptococcus pneumoniae, Haemophilius influenzae and Moraxella catarrhalis isolated in Hawaii
    Zheng, X
    Davis, E
    Singh, S
    Watase, R
    Hirata, K
    Reppun, T
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 15 (03) : 231 - 233
  • [27] In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against and Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Brueggemann, AB
    Kugler, KC
    Doern, GV
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1594 - 1597
  • [28] Mutant prevention concentration of four quinolones against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Nakai, Hajime
    Sato, Takumi
    Uno, Takashi
    Furukawa, Emiko
    Kawamura, Masato
    Takahashi, Hiroshi
    Watanabe, Akira
    Fujimura, Shigeru
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S82 - S82
  • [29] Activities of faropenem, an oral β-lactam, against recent US isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Critchley, IA
    Karlowsky, JA
    Draghi, DC
    Jones, ME
    Thornsberry, C
    Murfitt, K
    Sahm, DF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 550 - 555
  • [30] In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Doern, GV
    Pierce, G
    Brueggemann, AB
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 26 (01) : 39 - 42
12345